Skip to content. | Skip to navigation

University of Piemonte Orientale

Personal tools

You are here: Home / Teachers / Davide ROSSI / Davide ROSSI: List of publications

Navigation

Davide ROSSI: List of publications

  1. Ariatti C, Vivenza D, Capello D, Migliazza A, Parvis G, Fassone L, Buonaiuto D, Savinelli F, Rossi D, Saglio G, Gaidano G.
    COMMON VARIABLE IMMUNODEFICIENCY-RELATED LYMPHOMAS ASSOCIATE WITH MUTATIONS AND REARRANGEMENTS OF BCL-6: PATHOGENETIC AND HISTOGENETIC IMPLICATIONS.
    Hum Pathol, 31:871-873, 2000 
  2. Carbone A, Cilia AM, Gloghini A, Capello D, Fassone L, Perin T, Rossi D, Canzonieri V, De Paoli P, Vaccher E, Tirelli U, Volpe R, Gaidano G.
    CHARACTERIZATION OF A NOVEL HHV-8 POSITIVE CELL LINE REVEALS IMPLICATIONS FOR THE PATHOGENESIS AND CELL CYCLE CONTROL OF PRIMARY EFFUSION LYMPHOMA.
    Leukemia, 14:1301-1309, 2000 
  3. Fassone L, Gaidano G, Ariatti C, Vivenza D, Capello D, Gloghini A, Cilia AM, Buonaiuto D, Rossi D, Pastore C, Carbone A, Saglio G.
    THE ROLE OF CYTOKINES IN THE PATHOGENESIS AND MANAGEMENT OF AIDS-RELATED LYMPHOMAS.
    Leuk Lymphoma, 38:481-488, 2000
  4. Butler M, Iida S, Capello D, Rossi D, Rao PH, Nallasivam P, Louie DC, Chaganti S, Au T, Gascoyne RD, Gaidano G, Chaganti RSK, Dalla-Favera R.
    ALTERNATIVE TRANSLOCATION BREAKPOINT CLUSTER REGION 5’ TO BCL-6 IN B-CELL NON-HODGKIN’S LYMPHOMA.
    Cancer Res, 62:4089-4094, 2002
  5. Esteller M, Gaidano G, Goodman SN, Zagonel V, Capello D, Botto B, Rossi D, Gloghini A, Vitolo U, Carbone A, Baylin SB, Herman JG.
    HYPERMETHYLATION OF THE DNA REPAIR GENE O6-METHYLGUANINE DNA METHYLTRANSFERASE AND SURVIVAL OF PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA.
    J Natl Cancer Inst, 94:26-32, 2002
  6. Gaidano G, Cerri M, Capello D, Berra E, Deambrogi C, Rossi D, Larocca LM, Campo E, Gloghini A, Tirelli U, Carbone A.
    MOLECULAR HISTOGENESIS OF PLASMABLASTIC LYMPHOMA OF THE ORAL CAVITY.
    Br J Haematol, 119:622-628, 2002 
  7. Paulli M, Viglio A, Vivenza D, Capello D, Rossi D, Riboni R, Lucioni M, Incardona P, Boveri E, Bellosta M, Orlandi E, Borroni G, Lazzarino M, Berti E, Alessi E, Magrini U, Gaidano G.
    PRIMARY CUTANEOUS LARGE B-CELL LYMPHOMA OF THE LEG: HISTOGENETIC ANALYSIS OF A CONTROVERSIAL CLINICO-PATHOLOGIC ENTITY.
    Hum Pathol, 33:937-943, 2002 
  8. Rossi D, Gaidano G.
    MOLECULAR HETEROGENEITY OF DIFFUSE LARGE B-CELL LYMPHOMA: IMPLICATIONS FOR DISEASE MANAGEMENT AND PROGNOSIS.
    Hematology, 7:239-252, 2002 
  9. Capello D, Cerri M, Muti G, Berra E, Oreste P, Deambrogi C, Rossi D, Dotti G, Conconi A, Vigano M, Magrini U, Ippoliti G, Morra E, Gloghini A, Rambaldi A, Paulli M, Carbone A, Gaidano G.
    MOLECULAR HISTOGENESIS OF POSTTRANSPLANTATION LYMPHOPROLIFERATIVE DISORDERS.
    Blood, 102:3775-3785, 2003
  10. Capello D, Rossi D, Gaudino G, Carbone A, Gaidano G.
    SIMIAN VIRUS 40 INFECTION IN LYMPHOPROLIFERATIVE DISORDERS.
    Lancet, 361:88-89, 2003 
  11. Gaidano G, Pasqualucci L, Capello D, Berra E, Deambrogi C, Rossi D, Maria Larocca L, Gloghini A, Carbone A, Dalla-Favera R.
    ABERRANT SOMATIC HYPERMUTATION IN MULTIPLE SUBTYPES OF AIDS-ASSOCIATED NON-HODGKIN LYMPHOMA.
    Blood, 102:1833-1841, 2003 
  12. Rossi D, Gaidano G, Gloghini A, Deambrogi C, Franceschetti S, Berra E, Cerri M, Vendramin C, Conconi A, Viglio A, Muti G, Oreste P, Morra E, Paulli M, Capello D, Carbone A.
    FREQUENT ABERRANT PROMOTER HYPERMETHYLATION OF O6-METHYLGUANINE-DNA METHYLTRANSFERASE AND DEATH-ASSOCIATED PROTEIN KINASE GENES IN IMMUNODEFICIENCY-RELATED LYMPHOMAS.
    Br J Haematol, 123:475-478, 2003               
  13. Rossi D, Gaidano G.
    MESSENGERS OF CELL DEATH: APOPTOTIC SIGNALING IN HEALTH AND DISEASE.
    Haematologica, 88:212-218, 2003
  14. Toffoli G, Rossi D, Gaidano G, Cecchin E, Boiocchi M, Carbone A.
    METHYLENETETRAHYDROFOLATE REDUCTASE GENOTYPE IN DIFFUSE LARGE B-CELL LYMPHOMAS WITH AND WITHOUT HYPERMETHYLATION OF THE DNA REPAIR GENE O6-METHYLGUANINE DNA METHYLTRANSFERASE.
    Int J Biol Markers, 18:218-221, 2003 
  15. Capello D, Guarini A, Berra E, Mauro FR, Rossi D, Ghia E, Cerri M, Logan J, Foà R, Gaidano G.
    EVIDENCE OF BIASED IMMUNOGLOBULIN VARIABLE GENE USAGE IN HIGHLY STABLE B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA.
    Leukemia, 18:1941-1947, 2004
  16. Cerri M, Capello D, Muti G, Rambaldi A, Paulli M, Gloghini A, Berra E, Deambrogi C, Rossi D, Franceschetti S, Conconi A, Morra E, Pasqualucci L, Carbone A, Gaidano G.
    ABERRANT SOMATIC HYPERMUTATION IN POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS.
    Br J Haematol, 127:362-364, 2004
  17. Corcione A, Arduino N, Ferretti E, Raffaghello L, Roncella S, Rossi D, Fedeli F, Ottonello L, Trentin L, Dallegri F, Semenzato G, Pistoia V.
    CCL19 AND CXCL12 TRIGGER IN VITRO CHEMOTAXIS OF HUMAN MANTLE CELL LYMPHOMA B CELLS.
    Clin Cancer Res, 10:964-971,2004 
  18. Ferreri AJ, Dell'Oro S, Capello D, Ponzoni M, Iuzzolino P, Rossi D, Pasini F, Ambrosetti A, Orvieto E, Ferrarese F, Arrigoni G, Foppoli M, Reni M, Gaidano G.
    ABERRANT METHYLATION IN THE PROMOTER REGION OF THE REDUCED FOLATE CARRIER GENE IS A POTENTIAL MECHANISM OF RESISTANCE TO METHOTREXATE IN PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMAS.
    Br J Haematol, 126:657-664, 2004
  19. Forconi F, Capello D, Berra E, Rossi D, Gloghini A, Cerri M, Muti G, Morra E, Paulli M, Magrini U, Lucioni M, Rambaldi A, Lauria F, Carbone A, Stevenson FK, Gaidano G.
    INCIDENCE OF NOVEL N-GLYCOSYLATION SITES IN THE B-CELL RECEPTOR OF LYMPHOMAS ASSOCIATED WITH IMMUNODEFICIENCY.
    Br J Haematol, 124:604-609, 2004    
  20. Rossi D, Capello D, Gloghini A, Franceschetti S, Paulli M, Bhatia K, Saglio G, Vitolo U, Pileri SA, Esteller M, Carbone A, Gaidano G.
    ABERRANT PROMOTER METHYLATION OF MULTIPLE GENES THROUGHOUT THE CLINICO-PATHOLOGIC SPECTRUM OF B-CELL NEOPLASIA.
    Haematologica, 89:165-173, 2004
  21. Capello D, Rossi D, Gaidano G.
    POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: MOLECULAR BASIS OF DISEASE HISTOGENESIS AND PATHOGENESIS.
    Hematol Oncol, 23:61-67, 2005
  22. Rossi D, Cerri M, Capello D, Deambrogi C, Berra E, Franceschetti S, Alabiso O, Gloghini A, Paulli M, Carbone A, Pileri SA, Pasqualucci L, Gaidano G.
    ABERRANT SOMATIC HYPERMUTATION IN PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA.
    Leukemia, 19:2363-2366, 2005
  23. Sirianni MC, Libi F, Campagna M, Rossi D, Capello D, Sciaranghella G, Carbone A, Simonelli C, Monini P, Gaidano G, Ensoli B.
    DOWNREGULATION OF THE MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I MOLECULES BY HUMAN HERPESVIRUS TYPE 8 AND IMPAIRED NATURAL KILLER CELL ACTIVITY IN PRIMARY EFFUSION LYMPHOMA DEVELOPMENT.
    Br J Haematol, 130:92-95, 2005
  24. Capello D, Cerri M, Muti G, Lucioni M, Oreste P, Gloghini A, Berra E, Deambrogi C, Franceschetti S, Rossi D, Alabiso O, Morra E, Rambaldi A, Carbone A, Paulli M, Gaidano G.
    ANALYSIS OF IMMUNOGLOBULIN HEAVY AND LIGHT CHAIN VARIABLE GENES IN POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS.
    Hematol Oncol, 24:212-219, 2006
  25. Lucioni M, Capello D, Riboni R, Ippoliti G, Campana C, Bandiera L, Arcaini L, Rossi D, Cerri M, Dionigi P, Lazzarino M, Magrini U, Viganò M, Gaidano G, Paulli M.
    B-cell posttransplant lymphoproliferative disorders in heart and/or lungs recipients: clinical and molecular-histogenetic study of 17 cases from a single institution.
    Transplantation, 82:1013-1023, 2006
  26. Rinaldi A, Kwee I, Poretti G, Mensa A, Pruneti G, Capello D, Rossi D, Zucca E, Ponzoni M, Catalano C, Tibiletti MG, Paulli M, Gaidano G, Bertoni F.
    COMPARATIVE GENOME-WIDE PROFILING OF POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS AND DIFFUSE LARGE B-CELL LYMPHOMAS.
    Br J Haematol, 134:27-36, 2006
  27. Rossi D, Berra E, Cerri M, Deambrogi C, Barbieri C,Franceschetti S, Lunghi M, Conconi A,Paulli M,Matolcsy A,Pasqualucci L,Capello D,GaidanoG.
    ABERRANT SOMATIC HYPERMUTATION IN TRANSFORMATION OF FOLLICULAR LYMPHOMA AND CHRONIC LYMPHOCYTIC LEUKEMIA TO DIFFUSE LARGE B-CELL LYMPHOMA.
    Haematologica, 91:1405-1409, 2006
  28. RossiD, DeambrogiC, CapelloD, Cerri M, Lunghi D, Parvis G, SaglioG, Gaidano G, Cilloni D.
    JAK2V617F MUTATION IN LEUKAEMIC TRANSFORMATION OF PHILADELPHIA NEGATIVE CHRONIC MYELOPROLIFERATIVE DISORDERS.
    Br J Haematol, 135:267-268, 2006
  29. Rossi D, Cortini F, Deambrogi C, Barbieri C, Cerri M, Franceschetti S, Conconi A, Capello D, Gaidano G.
    USEFULNESS OF JAK2V617F MUTATION IN DISTINGUISHING IDIOPATHIC ERYTHROCYTOSIS FROM POLYCYTHEMIA VERA.
    Leuk Res, 31:97-101, 2007
  30. Rossi D, Cresta S, Destro T, Vendramin C, Bocchetta S, De Paoli L, Cerri M, Lunghi M, Gaidano G.
    JAK2V617F IN IDIOPATHIC VENOUS THROMBOEMBOLISM OCCURRING IN THE ABSENCE OF INHERITED OR ACQUIRED THROMBOPHILIA.
    Br J Haematol, 138:813-814, 2007
  31. Rossi D, De Paoli L, Franceschetti S, Capello D, Vendramin C, Lunghi M, Conconi A, Magnani C, Gaidano G.
    Prevalence and clinical characteristics of immune thrombocytopenic purpura in a cohort of monoclonal gammopathy of uncertain significance.
    Br J Haematol, 138:249-252, 2007
  32. Rossi D, Franceschetti S, Capello D, Conconi A, Casadio C, Valente G, Gaidano G.
    Simultaneous diagnosis of CD3+ T-cell large granular lymphocyte leukaemia and true thymic hyperplasia.
    Leuk Res, 31:1019-1021, 2007
  33. Rossi D, Franceschetti S, Capello D, De Paoli L, Lunghi M, Conconi A, Gaidano G.
    TRANSIENT MONOCLONAL EXPANSION OF CD8+/CD57+ T-CELL LARGE GRANULAR LYMPHOCYTES AFTER PRIMARY CYTOMEGALOVIRUS INFECTION.
    Am J Hematol, 82:1103-1105, 2007
  34. Rossi D, Franceschetti S, Cerri M, Conconi A, Lunghi M, Capello D, Cantello R, Gaidano G.
    HAIRY CELL LEUKAEMIA COMPLICATED BY ANTI-MAG PARAPROTEINEMIC DEMYELINATING NEUROPATHY: RESOLUTION OF NEUROLOGICAL SYNDROME AFTER CLADRIBRINE TREATMENT.
    Leuk Res, 31:873-876, 2007
  35. Rossi D, Gaidano G.
    CD40 PROMOTES LYMPHOMA FROM NUCLEAR HIDEAWAY.
    Blood, 110:1710-1711, 2007 
  36. Aydin S, Rossi D, Bergui L, D'Arena G, Ferrero E, Bonello L, Omede P, Novero D, Morabito F, Carbone A, Gaidano G, Malavasi F, Deaglio S.
    CD38 GENE POLYMORPHISM AND CHRONIC LYMPHOCYTIC LEUKEMIA: A ROLE IN TRANSFORMATION TO RICHTER’S SYNDROME?
    Blood, 111:5646-5653, 2008
  37. Capello D, Deambrogi C, Rossi D, Lischetti T, Piranda D, Cerri M, Spina V, Rasi S, Gaidano G, Lunghi M.
    EPIGENETIC INACTIVATION OF SUPPRESSORS OF CYTOKINE SIGNALING IN Ph-NEGATIVE CHRONIC MYELOPROLIFERATIVE DISORDERS.
    Br J Haematol, 141:504-511, 2008
  38. Capello D, Martini M, Gloghini A, Cerri M, Rasi S, Deambrogi C, Rossi D, Spina M, Tirelli U, Larocca LM, Carbone A, Gaidano G. 
    MOLECULAR ANALISYS OF IMMUNOGLOBULIN VARIABLE GENES IN HIV-RELATED NON HODGKIN LYMPHOMA REVEALS IMPLICATIONS FOR DISEASE PATHOGENESIS AND HISTOGENESIS.
    Haematologica, 93;1178-1185, 2008
  39. Forconi F, Poretti G, Kwee I, Sozzi, Rossi D, Rancoita PMV, Capello D, Rinaldi A, Zucca, Raspadori D, Spina V, Lauria F, Gaidano G, Bertoni F.
    High density genome-wide DNA profiling reveals a Remarkably stable profile in hairy cell leukaemia.
    Br J Haematol, 141:622-630, 2008
  40. Forconi F, Rinaldi A, Kwee I, Sozzi E, Raspadori D, Rancoita PM, Scandurra M, Rossi D, Deambrogi C, Capello D, Zucca E, Marconi D, Bomben R, Gattei V, Lauria F, Gaidano G, Bertoni F.
    Genome-wide DNA analysis identifies recurrent imbalances predicting outcome in chronic lymphocytic leukaemia with 17p deletion.
    Br J Haematol, 143:532-536, 2008
  41. Forconi F, Sozzi E, Rossi D, Sahota SS, Amato T, Raspadori T, Trentin L, Leoncini L, Gaidano G, Lauria F. 
    Selective influences in the expressed immunoglobulin heavy and light chain gene repertoire in hairy cell leukemia.
    Haematologica, 93:697-705, 2008
  42. Larocca A, Cavallo F, Magarotto V, Rossi D, Patriarca F, Boccadoro M, Palumbo A.
    Defibrotide: a review on clinical use and future development.
    Expert Opin Biol Ther, 8:1201-1212, 2008
  43. Rossi D, Cerri M, Capello D, Deambrogi C,Rossi FM, Zucchetto A, De Paoli L, Cresta S, Rasi S, Spina V, Franceschetti S, Lunghi M, Vendramin C, Bomben R, Ramponi A, Monga G, Conconi A, Magnani C, Gattei V, Gaidano G.
    Biological and Clinical Risk Factors of Chronic Lymphocytic Leukaemia Transformation to Richter's Syndrome.
    Br J Haematol, 142:202-215, 2008
  44. Rossi D, De Paoli L, Rossi FM, Cerri M, Deambrogi C, Rasi S, Zucchetto A, Capello D, Gattei V, Gaidano G.
    EARLY STAGE CHRONIC LYMPHOCYTIC LEUKAEMIA CARRYING UNMUTATED IGHV GENES IS AT RISK OF RECURRENT INFECTIONS DURING WATCH AND WAIT.
    Br J Haematol, 141:734-736, 2008 IF: 4.942
  45. Rossi D, Ramponi A, Franceschetti S, Stratta P, Gaidano G.
    BONE MARROW NECROSIS COMPLICATING POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER: RESOLUTION WITH RITUXIMAB.
    Leuk Res, 32:829-834, 2008
  46. Rossi D, Rasi S, Capello D, Gaidano G.
    PROGNOSTIC ASSESSMENT OF BCL2-938C>A POLYMORPHISM IN CHRONIC LYMPHOCYTIC LEUKEMIA.
    Blood, 111:466-468, 2008
  47. Rossi D, Zucchetto A, Rossi FM, Capello D, Cerri M, Deambrogi C, Cresta S, Rasi S, De Paoli L, Lobetti Bodoni C, Bulian P, Del Poeta G, Ladetto M, Gattei V, Gaidano G.
    CD49d expression is an independent risk factor of progressive disease in early stage chronic lymphocytic leukemia.
    Haematologica, 93:1575-1579, 2008
  48. Bomben R, Dal Bo M, Capello D, Forconi F, Maffei R, Laurenti L, Rossi D, Del Principe MI, Zucchetto A, Bertoni F, Rossi FM, Bulian P, Cattarossi I, Ilariucci F, Sozzi E, Spina V, Zucca E, Degan M, Lauria F, Del Poeta G, Efremov DG, Marasca R, Gaidano G, Gattei V.
    Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors: results from an Italian multicenter study.
    Br J Haematol, 144:492-506, 2009
  49. Capello D, Rasi S, Oreste P, Veronese S, Cerri M, Ravelli E, Rossi D, Minola E, Colosimo A, Gambacorta M, Muti G, Morra E, Gaidano G.
    Molecular characterization of post-transplant lymphoproliferative disorders of donor origin occurring in liver transplant recipients.
    J Pathol, 218:478-486, 2009
  50. Deambrogi C, Cresta S, Cerri M, Rasi S, De Paoli L, Ramponi A, Gaidano G, Rossi D.
    14q32 TRANSLOCATIONS AND RISK OF RICHTER’s TRANSFORMATION IN CHRONIC LYMPHOCYTIC LEUKAEMIA.
    Br J Haematol, 144:131-133, 2009
  51. Lunghi M, Riccomagno P, De Paoli L, Vendramin C, Conconi A, Gaidano G, Rossi D.
    Monitoring of cytomegalovirus reactivation during induction and nontransplant consolidation of acute leukemia.
    Am J Hematol, 84:697-698, 2009  
  52. Novak U, Rinaldi A, Kwee I, Nandula SV, Rancoita PM, Compagno M, Cerri M, Rossi D, Murty VV, Zucca E, Gaidano G, Dalla-Favera R, Pasqualucci L, Bhagat G, Bertoni F.
    The NF-{kappa}B negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas.
    Blood, 113:4918-4921, 2009
  53. Rossi D, Cerri M, Deambrogi C, Sozzi E, Cresta S, Rasi S, De Paoli L, Spina V, Gattei V, Capello D, Forconi F, Lauria F, Gaidano G. 
    THE PROGNOSTIC VALUE OF TP53 MUTATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA IS INDEPENDENT OF del17p13: IMPLICATIONS FOR OVERALL SURVIVAL AND CHEMOREFRACTORINESS.
    Clin Cancer Res, 15:995-1004, 2009 
  54. Rossi D, Gaidano G.
    RICHTER SYNDROME: MOLECULAR INSIGHTS AND CLINICAL PERSPECTIVES.
    Hematol Oncol, 27:1-10, 2009
  55. Rossi D, Lobetti Bodoni C, Genuardi E, Monitillo L, Drandi D, Cerri M, Deambrogi C, Ricca I, Rocci A, Ferrero S, Bernocco E, Capello D, De Paoli L, Bergui L, Boi M, Omedè P, Massaia M, Tarella C, Passera R, Boccadoro M, Gaidano G, Ladetto M.
    Telomere length is an independent predictor of survival, treatment requirement and Richter's syndrome transformation in chronic lymphocytic leukemia.
    Leukemia, 23:1062-1072, 2009
  56. Rossi D, Rasi S, Franceschetti S, Capello D, Castelli A, De Paoli L, Ramponi A, Chiappella A, Pogliani EM, Vitolo U, Kwee I, Bertoni F, Conconi A, Gaidano G.
    Analysis of the host pharmacogenetic background for prediction of outcome and toxicity in diffuse large B-cell lymphoma treated with R-CHOP21.
    Leukemia, 23:1118-1126, 2009
  57. Rossi D, Sala L, Minisini R, Fabris C, Falleti E, Cerri M, Burlone ME, Toniutto P, Gaidano G, Pirisi M.
    Occult hepatitis B virus infection of peripheral blood mononuclear cells among treatment-naive patients with chronic lymphocytic leukemia.
    Leuk Lymphoma, 50:604-611, 2009 IF: 2.492
  58. Rossi D, Sozzi E, Puma A, De Paoli L, Rasi S, Spina V, Gozzetti A, Tassi M, Cencini E, Raspadori D, Pinto V, Bertoni F, Gattei V, Lauria F, Gaidano G, Forconi F.
    The prognosis of clinical monoclonal B cell lymphocytosis differs from prognosis of Rai 0 chronic lymphocytic leukaemia and is recapitulated by biological risk factors.
    Br J Haematol, 146:64-75, 2009
  59. Rossi D, Spina V, Cerri M, Rasi S, Deambrogi C, De Paoli L, Laurenti L, Maffei R, Forconi F, Bertoni F, Zucca E, Agostinelli C, Cabras A, Lucioni M, Martini M, Magni M, Deaglio S, Ladetto M, Nomdedeu JF, Besson C, Ramponi A, Canzonieri V, Paulli M, Marasca R, Larocca LM, Carbone A, Pileri SA, Gattei V, Gaidano G.
    STEREOTYPED B-CELL RECEPTOR IS AN INDEPENDENT RISK FACTOR OF CHRONIC LYMPHOCYTIC LEUKEMIA TRANSFORMATION TO RICHTER SYNDROME.
    Clin Cancer Res, 15:4415-4422, 2009 
  60. Rossi D.
    THYROID LYMPHOMA. BEYOND ANTIGEN STIMULATION.
    Leuk Res, 33:607-609, 2009
  61. Rossi F, Petrucci MT, Guffanti A, Marcheselli L, Rossi D, Callea V, Vincenzo F, De Muro M, Baraldi A, Villani O, Musto P, Bacigalupo A, Gaidano G, Avvisati G, Goldaniga M, Depaoli L, Baldini L.
    Proposal and validation of prognostic scoring systems for IgG and IgA monoclonal gammopathies of undetermined significance.
    Clin Cancer Res, 15:4439-4445, 2009   
  62. Zucchetto A, Benedetti D, Tripodo C, Bomben R, Dal Bo M, Marconi D, Bossi F, Lorenzon D, Degan M, Rossi FM, Rossi D, Bulian P, Franco V, Del Poeta G, Deaglio S, Gaidano G, Tedesco F, Malavasi F, Gattei V.
    CD38/CD31, the CCL3 and CCL4 chemokines, and CD49d/vascular cell adhesion molecule-1 are interchained by sequential events sustaining chronic lymphocytic leukemia cell survival.
    Cancer Res, 69:4001-4009, 2009
  63. Bomben R, Dal Bo M, Capello D, Forconi F, Bertoni F, Maffei R, Laurenti L, Rossi D, Zucca E, Degan M, Marasca R, Efremov DG, Del Poeta G, Gaidano G, Gattei V.
    IGHD3-3 fails to behave as unfavourable prognostic marker in chronic lymphocytic leukaemia.
    Br J Haematol, 149:299-302, 2010 IF: 4.942
  64. Bomben R, Dal-Bo M, Benedetti D, Capello D, Forconi F, Marconi D, Bertoni F, Maffei R, Laurenti L, Rossi D, Del Principe MI, Luciano F, Sozzi E, Cattarossi I, Zucchetto A, Rossi FM, Bulian P, Zucca E, Nicoloso MS, Degan M, Marasca R, Efremov DG, Del Poeta G, Gaidano G, Gattei V.
    Expression of mutated IGHV3-23 genes in chronic lymphocytic leukemia identifies a disease subset with peculiar clinical and biological features.
    Clin Cancer Res, 16:620-628, 2010 
  65. Bringhen S, Larocca A, Rossi D, Cavalli M, Genuardi M, Ria R, Gentili S, Patriarca F, Nozzoli C, Levi A, Guglielmelli T, Benevolo G, Callea V, Rizzo V, Cangialosi C, Musto P, De Rosa L, Liberati AM, Grasso M, Falcone AP, Evangelista A, Cavo M, Gaidano G, Boccadoro M, Palumbo A.
    Efficacy and safety of once-weekly bortezomib in multiple myeloma patients.
    Blood, 116:4745-4753, 2010
  66. Capello D, Scandurra M, Poretti G, Rancoita PM, Mian M, Gloghini A, Deambrogi C, Martini M, Rossi D, Greiner TC, Chan WC, Ponzoni M, Montes Moreno S, Piris MA, Canzonieri V, Spina M, Tirelli U, Inghirami G, Rinaldi A, Zucca E, Dalla-Favera R, Cavalli F, Larocca LM, Kwee I, Carbone A, Gaidano G, Bertoni F.
    Genome wide DNA-profiling of HIV-related B-cell lymphomas.
    Br J Haematol, 148:245-255, 2010 
  67. Crowther-Swanepoel D, Corre T, Lloyd A, Gaidano G, Olver B, Bennett FL, Doughty C, Toniolo D, Caligaris-Cappio F, Ghia P, Rossi D, Rawstron AC, Catovsky D, Houlston RS.
    Inherited genetic susceptibility to monoclonal B-cell lymphocytosis.
    Blood, 2116:5957-5960, 2010
  68. Deambrogi C, De Paoli L, Fangazio M, Cresta S, Rasi S, Spina V, Gattei V, Gaidano G, Rossi D.
    Analysis of the REL, BCL11A and MYCN proto-oncogenes belonging to the 2p AMPLICON IN CHRONIC LYMPHOCYTIC LEUKEMIA.
    Am J Hematol, 85:541-544, 2010
  69. Lunghi M, Casorzo L, De Paoli L, Riccomagno P, Rossi D, Gaidano G.
    Derivative (1)t(1;16)(p11;p11.1) in myelodysplastic syndrome: a case report and review of the literature.
    Cancer Genet Cytogenet, 196:89-92, 2010
  70. Maffei R, Martinelli S, Santachiara R, Rossi D, Guarnotta C, Sozzi E, Zucchetto A, Rigolin GM, Fiorcari S, Castelli I, Fontana M, Coluccio V, Leonardi G, Zucchini P, Tripodo C, Cuneo A, Gattei V, Del Poeta G, Forconi F, Gaidano G, Torelli G, Marasca R.
    Angiopoietin-2 plasma dosage predicts time to first treatment and overall survival in chronic lymphocytic leukemia.
    Blood, 116:584-592, 2010
  71. Palumbo A, Bringhen S, Rossi D, Cavalli M, Larocca A, Ria R, Offidani M, Patriarca F, Nozzoli C, Guglielmelli T, Benevolo G, Callea V, Baldini L, Morabito F, Grasso M, Leonardi G, Rizzo M, Falcone AP, Gottardi D, Montefusco V, Musto P, Petrucci MT, Ciccone G, Boccadoro M.
    Bortezomib-melphalan-prednisone-thalidomide followed by maintenance with bortezomib-thalidomide compared with bortezomib-melphalan-prednisone for initial treatment of multiple myeloma: a randomized controlled trial.
    J Clin Oncol, 28:5101-5109, 2010
  72. Palumbo A, Larocca A, Genuardi M, Kotwica K, Gay F, Rossi D, Benevolo G, Magarotto V, Cavallo F, Bringhen S, Rus C, Masini L, Iacobelli M, Gaidano G, Mitsiades C, Anderson K, Boccadoro M, Richardson P; for the Italian Multiple Myeloma Network, GIMEMA.
    Melphalan, prednisone, thalidomide and defibrotide in relapsed/refractory multiple myeloma: results of multicenter phase I/II trial.
    Haematologica, 95:1144-1149, 2010
  73. Paulli M, Arcaini L, Lucioni M, Boveri E, Capello D, Passamonti F, Merli M, Rattotti S, Rossi D, Riboni R, Berti E, Magrini U, Bruno R, Gaidano G, Lazzarino M.
    Subcutaneous 'lipoma-like' B-cell lymphoma associated with HCV infection: a new presentation of primary extranodal marginal zone B-cell lymphoma of MALT.
    Ann Oncol, 21:1189-1195, 2010                            
  74. Rasi S, Forconi F, Bruscaggin A, Sozzi E, Gaidano G, Rossi D.
    Impact of the host genetic background on prognosis of chronic lymphocytic leukemia.
    Blood, 115:1106-1107, 2010
  75. Rinaldi A, Capello D, Scandurra M, Greiner TC, Chan WC, Bhagat G, Rossi D, Morra E, Paulli M, Rambaldi A, Rancoita PM, Inghirami G, Ponzoni M, Montes Moreno S, Piris MA, Mian M, Chigrinova E, Zucca E, Dalla-Favera R, Gaidano G, Kwee I, Bertoni F.
    Single nucleotide polymorphism-arrays provide new insights in the pathogenesis of post-transplant diffuse large B-cell lymphoma.
    Br J Haematol, 149:569-577, 2010
  76. Rossi D, Deambrogi C, Monti S, Cresta S, De Paoli L, Fangazio M, Giardini I, Brnasconi P, Gaidano G.
    BCL3 TRANSLOCATION IN CLL WITH TYPICAL PHENOTYPE: ASSESMENT OF FREQUENCY, ASSOCIATION WITH CYTOGENETIC SUBGROUPS, AND PROGNOSTIC SIGNIFICANCE.
    Br J Haematol, 150:702-704, 2010
  77. Rossi D, Fangazio M, De Paoli L, Puma A, Riccomagno P, Pinto V, Zigrossi P, Ramponi A, Monga G, Gaidano G.
    BETA-2-MICROGLOBULIN IS AN INDEPENDENT PREDICTOR OF PROGRESSION IN ASYMPTOMATIC MULTIPLE MYELOMA.
    Cancer, 116:2188-2200, 2010
  78. Rossi D, Gaidano G.
    Biological and clinical significance of stereotyped B-cell receptors in chronic lymphocytic leukemia.
    Haematologica, 95:1992-1995, 2010
  79. Rossi D, Lobetti Bodoni C, Zucchetto A, Rasi S, De Paoli L, Fangazio M, Rossi FM, Ladetto M,  Gattei V, Gaidano G.
    LOW CD49d EXPRESSION AND LONG TELOMERE IDENTIFY A CHRONIC LYMPHOCYTIC LEUKEMIA SUBSET WITH HIGHLY FAVOURABLE OUTCOME.
    Am J Hematol, 85:619-622, 2010
  80. Rossi FM, Del Principe MI, Rossi D, Irno Consalvo M, Luciano F, Zucchetto A, Bulian P, Bomben R, Dal Bo M, Fangazio M, Benedetti D, Degan M, Gaidano G, Del Poeta G, Gattei V.
    Prognostic impact of ZAP-70 expression in chronic lymphocytic leukemia: mean fluorescence intensity T/B ratio versus percentage of positive cells.
    J Transl Med, 8:23, 2010
  81. Scandurra M, Rossi D, Deambrogi C, Rancoita PM, Chigrinova E, Mian M, Cerri M, Rasi S, Sozzi E, Forconi F, Ponzoni M, Montes Moreno S, Piris MA, Inghirami G, Zucca E, Gattei V, Rinaldi A, Kwee I, Gaidano G, Bertoni F.
    Genomic profiling of Richter's syndrome: recurrent lesions and differences with de novo diffuse large B-cell lymphomas.
    Hematol Oncol, 28:62-67, 2010
  82. Stratta P, Airoldi A, Izzo C, Rossi D, Gaidano G.
    Free light-chains and renal disorders: when small is worse.
    Lancet, 376:1221, 2010
  83. Stratta P, Gravellone L, Cena T, Rossi D, Gaidano G, Fenoglio R, Lazzarich E, Quaglia M, Airoldi A, Bozzola C, Monga G, Valente G, Canavese C, Magnani C.
    Renal outcome and monoclonal immunoglobulin deposition disease in 289 old patients with blood cell dyscrasias: A single center experience.
    Crit Rev Oncol Hematol, 2011;79:31-42.
  84. Vaisitti T, Aydin S,Rossi D, Cottino F, Bergui L, D’Arena G, Bonello L, Horenstein AL,  Brennan P, Pepper C, Gaidano G, Malavasi F, Deaglio S.
    CD38 increases CXCL12-mediated signals and homing of chronic lymphocytic leukemia cells.
    Leukemia, 24:958-969, 2010
  85. Zibellini S, Capello D, Forconi F, Marcatili P, Rossi D, Rattotti S, Franceschetti S, Sozzi E, Cencini E, Marasca R, Baldini L, Tucci A, Bertoni F, Passamonti F, Orlandi E, Varettoni M, Merli M, Rizzi S, Gattei V, Tramontano A, Paulli M, Gaidano G, Arcaini L.
    Stereotyped patterns of B-cell receptor in splenic marginal zone lymphoma.
    Haematologica, 95:1792-1796, 2010
  86. Audrito V, Vaisitti T, Rossi D, Gottardi D, D'Arena G, Laurenti L, Gaidano G, Malavasi F, Deaglio S.
    Nicotinamide blocks proliferation and induces apoptosis of chronic lymphocytic leukemia cells through activation of the p53/miR-34a/SIRT1 tumor suppressor network.
    Cancer Res, 71:4473-4483, 2011
  87. Bulian P, Tarnani M, Rossi D, Forconi F, Del Poeta G, Bertoni F, Zucca E, Montillo M, Pozzato G, Deaglio S, D'Arena G, Efremov D, Marasca R, Lauria F, Gattei V, Gaidano G, Laurenti L.
    Multicentre validation of a prognostic index for overall survival in chronic lymphocytic leukaemia.
    Hematol Oncol, 29:91-99, 2011
  88. Crowther-Swanepoel D, Di Bernardo MC, Jamroziak K, Karabon L, Frydecka I, Deaglio S, D'Arena G, Rossi D, Gaidano G, Olver B, Lloyd A, Broderick P, Laurenti L, Szemraj-Rogucka Z, Robak T, Catovsky D, Houlston RS.
    Common genetic variation at 15q25.2 impacts on chronic lymphocytic leukaemia risk.
    Br J Haematol, 154:229-233, 2011
  89. Dal Bo M, Rossi FM, Rossi D, Deambrogi C, Bertoni F, Del Giudice I, Palumbo G, Nanni M, Rinaldi A, Kwee I, Tissino E, Corradini G, Gozzetti A, Cencini E, Ladetto M, Coletta AM, Luciano F, Bulian P, Pozzato G, Laurenti L, Forconi F, Di Raimondo F, Marasca R, Del Poeta G, Gaidano G, Foà R, Guarini A, Gattei V.
    13q14 deletion size and number of deleted cells both influence prognosis in chronic lymphocytic leukemia.
    Genes Chromosomes Cancer, 50:633-643, 2011
  90. Dal-Bo M, Del Giudice I, Bomben R, Capello D, Bertoni F, Forconi F, Laurenti L, Rossi D, Zucchetto A, Pozzato G, Marasca R, Efremov DG, Guarini A, Del Poeta G, Foà R, Gaidano G, Gattei V.
    B-cell receptor, clinical course and prognosis in chronic lymphocytic leukaemia: the growing saga of the IGHV3 subgroup gene usage.
    Br J Haematol, 153:3-14, 2011
  91. Fabbri G, Rasi S, Rossi D, Trifonov V, Khiabanian H, Ma J, Grunn A, Fangazio M, Capello D, Monti S, Cresta S, Gargiulo E, Forconi F, Guarini A, Arcaini L, Paulli M, Laurenti L, Larocca LM, Marasca R, Gattei V, Oscier D, Bertoni F, Mullighan CG, Foá R, Pasqualucci L, Rabadan R, Dalla-Favera R, Gaidano G.
    Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation.
    J Exp Med, 208:1389-1401, 2011
  92. Fangazio M, De Paoli L, Rossi D, Gaidano G.
    Predictive markers and driving factors behind Richter syndrome development.
    Expert Rev Anticancer Ther, 11:433-442, 2011
    Ferretti E, Bertolotto M, Deaglio S, Tripodo C, Ribatti D, Audrito V, Blengio F, Matis S, Zupo S, Rossi D, Ottonello L, Gaidano G, Malavasi F, Pistoia V, Corcione A.
    A novel role of the CX3CR1/CX3CL1 system in the cross-talk between chronic lymphocytic leukemia cells and tumor microenvironment.
    Leukemia, 25:1268-1277, 2011
  93. Gay F, Larocca A, Wijermans P, Cavallo F, Rossi D, Schaafsma R, Genuardi M, Romano A, Liberati AM, Siniscalchi A, Petrucci MT, Nozzoli C, Patriarca F, Offidani M, Ria R, Omedè P, Bruno B, Passera R, Musto P, Boccadoro M, Sonneveld P, Palumbo A.
    Complete response correlates with long-term progression-free and overall survivals in elderly myeloma treated with novel agents: analysis of 1175 patients.
    Blood, 117:3025-3031, 2011
  94. Laurenti L, Tarnani M, Nichele I, Ciolli S, Cortelezzi A, Forconi F, Rossi D, Mauro FR, D'Arena G, Del Poeta G, Montanaro M, Morabito F, Musolino C, Callea V, Falchi L, Tedeschi A, Ambrosetti A, Gaidano G, Leone G, Foà R.
    The coexistence of chronic lymphocytic leukemia and myeloproliperative neoplasms: A retrospective multicentric GIMEMA experience.
    Am J Hematol,  208:1389-1401, 2011
  95. Morabito F, Gentile M, Mazzone C, Rossi D, Di Raimondo F, Bringhen S, Ria R, Offidani M, Patriarca F, Nozzoli C, Petrucci MT, Benevolo G, Vincelli I, Guglielmelli T, Grasso M, Marasca R, Baldini L, Montefusco V, Musto P, Cascavilla N, Majolino I, Musolino C, Cavo M, Boccadoro M, Palumbo A.
    Safety and efficacy of bortezomib-melphalan-prednisone-thalidomide followed by bortezomib-thalidomide maintenance (VMPT-VT) versus bortezomib-melphalan-prednisone (VMP) in untreated multiple myeloma patients with renal impairment.
    Blood, 118:5759-5766, 2011
  96. Palumbo A, Cavo M, Bringhen S, Zamagni E, Romano A, Patriarca F, Rossi D, Gentilini F, Crippa C, Galli M, Nozzoli C, Ria R, Marasca R, Montefusco V, Baldini L, Elice F, Callea V, Pulini S, Carella AM, Zambello R, Benevolo G, Magarotto V, Tacchetti P, Pescosta N, Cellini C, Polloni C, Evangelista A, Caravita T, Morabito F, Offidani M, Tosi P, Boccadoro M.
    Aspirin, Warfarin, or Enoxaparin Thromboprophylaxis in Patients With Multiple Myeloma Treated With Thalidomide: A Phase III, Open-Label, Randomized Trial.
    J Clin Oncol, 29:986-993, 2011
  97. Pasqualucci L, Dominguez-Sola D, Chiarenza A, Fabbri G, Grunn A, Trifonov V, Kasper LH, Lerach S, Tang H, Ma J, Rossi D, Murty VV, Mullighan CG, Gaidano G, Rabadan R, Brindle PK, Dalla-Favera R.
    Inactivating mutations of acetyltransferase genes in B-cell lymphoma.
    Nature, 471:189-195, 2011
  98. Pasqualucci L, Trifonov V, Fabbri G, Ma J, Rossi D, Chiarenza A, Wells VA, Grunn A, Messina M, Elliot O, Chan J, Bhagat G, Chadburn A, Gaidano G, Mullighan CG, Rabadan R, Dalla-Favera R.
    Analysis of the coding genome of diffuse large B-cell lymphoma.
    Nat Genet, 43:830-837, 2011
  99. Rasi S, Bruscaggin A, Rinaldi A, Cresta S, Fangazio M, De Paoli L, Monti S, Gargiulo E, Kwee I, Foà R, Bertoni F, Gaidano G, Rossi D.
    Saliva is a reliable and practical source of germline DNA for genome-wide studies in chronic lymphocytic leukemia.
    Leuk Res, 35:1419-1422, 2011
  100. Rasi S, Spina V, Bruscaggin A, Vaisitti T, Tripodo C, Forconi F, De Paoli L, Fangazio M, Sozzi E, Cencini E, Laurenti L, Marasca R, Visco C, Xu-Monette ZY, Gattei V, Young KH, Malavasi F, Deaglio S, Gaidano G, Rossi D.
    A variant of the LRP4 gene affects the risk of chronic lymphocytic leukaemia transformation to Richter syndrome.
    Br J Haematol, 152:284-294, 2011
  101. Rinaldi A, Mian M, Kwee I, Rossi D, Deambrogi C, Mensah AA, Forconi F, Spina V, Cencini E, Drandi D, Ladetto M, Santachiara R, Marasca R, Gattei V, Cavalli F, Zucca E, Gaidano G, Bertoni F.
    Genome-wide DNA profiling better defines the prognosis of chronic lymphocytic leukaemia.
    Br J Haematol, 154:590-599, 2011
  102. Rinaldi A, Ponzoni M, Uccella S, Rossi D, Gaidano G, Facchetti F, Pruneri G, Tibiletti MG, Capella C, Zucca E, Doglioni C, Catapano C, Bertoni F.
    In vitro efficacy of tyrosine kinase inhibitors: SYK and BCR-ABL inhibitors in lymphomas.
    Hematol Oncol, 29:164-166, 2011
  103. Rossi D, Bruscaggin A, Spina V, Rasi S, Khiabanian H, Messina M, Fangazio M, Vaisitti T, Monti S, Chiaretti S, Guarini A, Del Giudice I, Cerri M, Cresta S, Deambrogi C, Gargiulo E, Gattei V, Forconi F, Bertoni F, Deaglio S, Rabadan R, Pasqualucci L, Foà R, Dalla-Favera R, Gaidano G.
    Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness.
    Blood, 118:6904-6908, 2011
  104. Rossi D, Deaglio S, Dominguez-Sola D, Rasi S, Vaisitti T, Agostinelli C, Spina V, Bruscaggin A, Monti S, Cerri M, Cresta S, Fangazio M, Arcaini L, Lucioni M, Marasca R, Thieblemont C, Capello D, Facchetti F, Kwee I, Pileri SA, Foà R, Bertoni F, Dalla-Favera R, Pasqualucci L, Gaidano G.
    Alteration of BIRC3 and multiple other NF-{kappa}B pathway genes in splenic marginal zone lymphoma.
    Blood, 118:4930-4934, 2011
  105. Rossi D, Gaidano G.
    Tracking the biological risk of coronary artery disease in HIV-infected individuals: the case of circulating endothelial progenitor cells.
    AIDS, 25: 379-381, 2011
  106. Rossi D, Rasi S, Di Rocco A, Fabbri A, Forconi F, Gloghini A, Bruscaggin A, Franceschetti S, Fangazio M, De Paoli L, Bruna R, Capello D, Chiappella A, Lobetti Bodoni C, Giachelia M, Tisi MC, Pogliani EM, Lauria F, Ladetto M, Hohaus S, Martelli M, Vitolo U, Carbone A, Foà R, Gaidano G.
    The host genetic background of DNA repair mechanisms is an independent predictor of survival in diffuse large B-cell lymphoma.
    Blood, 117:2405-2413, 2011
  107. Rossi D, Spina V, Deambrogi C, Rasi S, Laurenti L, Stamatopoulos K, Arcaini L, Lucioni M, Rocque GB, Xu-Monette ZY, Visco C, Chang J, Chigrinova E, Forconi F, Marasca R, Besson C, Papadaki T, Paulli M, Larocca LM, Pileri SA, Gattei V, Bertoni F, Foà R, Young KH, Gaidano G.
    The genetics of Richter syndrome reveals disease heterogeneity and predicts survival post-transformation.
    Blood, 117:3391-3401, 2011
  108. Saborit-Villarroya I, Vaisitti T, Rossi D, D'Arena G, Gaidano G, Malavasi F, Deaglio S.
    E2A is a transcriptional regulator of CD38 expression in chronic lymphocytic leukemia.
    Leukemia, 25:479-488, 2011
  109. Serra S, Horenstein AL, Vaisitti T, Brusa D, Rossi D, Laurenti L, D'Arena G, Coscia M, Tripodo C, Inghirami G, Robson SC, Gaidano G, Malavasi F, Deaglio S.
    CD73-generated extracellular adenosine in chronic lymphocytic leukemia creates local conditions counteracting drug-induced cell death.
    Blood, 118:6141-6152, 2011
  110. Spina F, Montefusco V, Crippa C, Citro A, Sammassimo S, Olivero B, Gentili S, Galli M, Guglielmelli T, Rossi D, Falcone AP, Grasso M, Patriarca F, De Muro M, Corradini P.
    Lenalidomide can induce long-term responses in patients with multiple myeloma relapsing after multiple chemotherapy lines, in particular after allogeneic transplant.
    Leuk Lymphoma,52:1262-1270, 2011
  111. Wade R, Di Bernardo MC, Richards S, Rossi D, Crowther-Swanepoel D, Gaidano G, Oscier DG, Catovsky D, Houlston RS.
    Association between single nucleotide polymorphism-genotype and outcome of patients with chronic lymphocytic leukemia in a randomized chemotherapy trial.
    Haematologica, 96:1496-1503, 2011
  112. Arcaini L, Rossi D.
    Nuclear factor-kB dysregulation in splenic marginal zone lymphoma: new therapeutic opportunities.
    Haematologica, 97:638-640, 2012
  113. Bomben R, Gobessi S, Dal Bo M, Volinia S, Marconi D, Tissino E, Benedetti D, Zucchetto A, Rossi D, Gaidano G, Del Poeta G, Laurenti L, Efremov DG, Gattei V.
    The miR-17~92 family regulates the response to Toll-like receptor 9 triggering of CLL cells with unmutated IGHV genes.
    Leukemia, 26:1584-93, 2012
  114. Bulian P, Rossi D, Forconi F, Del Poeta G, Bertoni F, Zucca E, Montillo M, Pozzato G, D'Arena G, Efremov D, Marasca R, Lauria F, Gaidano G, Gattei V, Laurenti L.
    IGHV gene mutational status and 17p deletion are independent molecular predictors in a comprehensive clinical-biological prognostic model for overall survival prediction in chronic lymphocytic leukemia.
    J Transl Med, 10:18, 2012
  115. Del Giudice I, Rossi D, Chiaretti S, Marinelli M, Tavolaro S, Gabrielli S, Laurenti L, Marasca R, Rasi S, Fangazio M, Guarini A, Gaidano G, Foa' R.
    NOTCH1 mutations in +12 chronic lymphocytic leukemia (CLL) confer an unfavorable prognosis, induce a distinctive transcriptional profiling and refine the intermediate prognosis of +12 CLL.
    Haematologica,97:437-441, 2012
  116. Falco P, Cavallo F, Larocca A, Rossi D, Guglielmelli T, Rocci A, Grasso M, Siez ML, De Paoli L, Oliva S, Molica S, Mina R, Gay F, Benevolo G, Musto P, Omedè P, Freilone R, Bringhen S, Carella AM, Gaidano G, Boccadoro M, Palumbo A.
    Lenalidomide-prednisone induction followed by lenalidomide-melphalan-prednisone consolidation and lenalidomide-prednisone maintenance in newly diagnosed elderly unfit myeloma patients.
    Leukemia, 27:695-701, 2013
  117. Ferrero S, Capello D, Svaldi M, Boi M, Gatti D, Drandi D, Rossi D, Barbiero S, Mantoan B, Mantella E, Zanni M, Ghione P, Larocca A, Passera R, Bertoni F, Gattei V, Forconi F, Laurenti L, Del Poeta G, Marasca R, Cortelazzo S, Gaidano G, Palumbo A, Boccadoro M, Ladetto M.
    Multiple myeloma shows no intra-disease clustering of immunoglobulin heavy chain genes.
    Haematologica,97:849-853, 2012
  118. Forconi F, Potter KN, Sozzi E, Henderson I, Cencini E, Rossi D, Bomben R, Gattei V, Gaidano G, Packham G, Stevenson FK.
    The IGHV1-69/IGHJ3 recombinations of unmutated CLL are distinct from those of normal B cells.
    Blood,119:2106-2109, 2012
  119. Gozzetti A, Cerase A, Lotti F, Rossi D, Palumbo A, Petrucci MT, Patriarca F, Nozzoli C, Cavo M, Offidani M, Floridia M, Berretta S, Vallone R, Musto P, Lauria F; for the GIMEMA (Gruppo Italiano Malattie Ematologiche dell'Adulto) Myeloma Working Party.
    Extramedullary intracranial localization of multiple myeloma and treatment with novel agents: A retrospective survey of 50 patients.
    Cancer, 118:1574-1584, 2012
  120. Greco M, Capello D, Bruscaggin A, Spina V, Rasi S, Monti S, Ciardullo C, Cresta S, Fangazio M, Gaidano G, Foà R, Rossi D.
    Analysis of SF3B1 mutations in monoclonal B-cell lymphocytosis.
    Hematol Oncol, 2012 Mar 29. doi: 10.1002/hon.2013.
  121. Kwee I, Rinaldi A, Rancoita P, Rossi D, Capello D, Forconi F, Giuliani N, Piva R, Inghirami G, Gaidano G, Zucca E, Bertoni F.
    Integrated DNA copy number and methylation profiling of lymphoid neoplasms using a single array.
    Br J Haematol, 156:354-357, 2012
    Maldi E, Monga G, Rossi D, Tosoni A, Mezzapelle R, Boldorini R.
    ulExtra-osseous Ewing sarcoma of the thyroid gland mimicking lymphoma recurrence: a case report.
    Pathol Res Pract, 208:356-359, 2012
  122. Mensah AA, Rinaldi A, Ponzoni M, Canzonieri V, Uccella S, Rossi D, Bhagat G, Gaidano G, Zucca E, Bertoni F.
    Absence of NOTCH1 gene mutations in MALT lymphomas.
    Br J Haematol, 157:382-384, 2012
  123. Mian M, Rinaldi A, Mensah AA, Rossi D, Ladetto M, Forconi F, Marasca R, Gattei V, Zucca E, Cavalli F, Gaidano G, Kwee I, Bertoni F.
    Del(13q14.3) length matters: an integrated analysis of genomic, fluorescence in situ hybridization and clinical data in 169 chronic lymphocytic leukaemia patients with 13q deletion alone or a normal karyotype.
    Hematol Oncol, 30:46-49, 2012
  124. Pinato DJ, Rossi D, Minh MT, Toniutto P, Boccato E, Minisini R, Gaidano G, Pirisi M.
    Hepatitis B virus and lymphomagenesis: Novel insights into an occult relationship.
    Dig Liver Dis, 44:235-238, 2012
  125. Pospisilova S, Gonzalez D, Malcikova J, Trbusek M, Rossi D, Kater AP, Cymbalista F, Eichhorst B, Hallek M, Döhner H, Hillmen P, van Oers M, Gribben J, Ghia P, Montserrat E, Stilgenbauer S, Zenz T; European Research Initiative on CLL (ERIC).
    ERIC recommendations on TP53 mutation analysis in chronic lymphocytic leukemia.
    Leukemia, 26:1458-1461, 2012 
  126. Rasi S, Monti S, Spina V, Foà R, Gaidano G, Rossi D.
    Analysis of NOTCH1 mutations in monoclonal B cell lymphocytosis.
    Haematologica, 97:153-154, 2012
  127. Rossi D, Fangazio M, Rasi S, Vaisitti T, Monti S, Cresta S, Chiaretti S, Del Giudice I, Fabbri G, Bruscaggin A, Spina V, Deambrogi C, Marinelli M, Famà R, Greco M, Daniele G, Forconi F, Gattei V, Bertoni F, Deaglio S, Pasqualucci L, Guarini A, Dalla-Favera R, Foà R, Gaidano G.
    Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild type chronic lymphocytic leukemia.
    Blood, 119:2854-2862, 2012
  128. Rossi D, Spina V, Forconi F, Capello D, Fangazio M, Rasi S, Martini M, Gattei V, Ramponi A, Larocca LM, Bertoni F, Gaidano G.
    Molecular history of Richter syndrome: Origin from a cell already present at the time of chronic lymphocytic leukemia diagnosis.
    Int J Cancer, 130:3006-3010, 2012
  129. Rossi D, Rasi S, Fabbri G, Spina V, Fangazio M, Forconi F, Marasca R, Laurenti L, Bruscaggin A, Cerri M, Monti S, Cresta S, Famà R, De Paoli L, Bulian P, Gattei V, Guarini A, Deaglio S, Capello D, Rabadan R, Pasqualucci L, Dalla-Favera R, Foà R, Gaidano G.
    Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia.
    Blood, 119:521-529, 2012
  130. Rossi D, Rasi S, Spina V, Fangazio M, Monti S, Greco M, Ciardullo C, Famà R, Cresta S, Bruscaggin A, Laurenti L, Martini M, Musto P, Forconi F, Marasca R, Larocca LM, Foà R, Gaidano G.
    Different impact of NOTCH1 and SF3B1 mutations on the risk of chronic lymphocytic leukemia transformation to Richter syndrome.
    Br J Haematol, 158:426-429, 2012
  131. Rossi D, Gaidano G.
    ATM and chronic lymphocytic leukemia: mutations, and not only deletions, matter.
    Haematologica,97:5-8, 2012
  132. Rossi D, Trifonov V, Fangazio M, Bruscaggin A, Rasi S, Spina V, Monti S, Vaisitti T, Arruga F, Famà R, Ciardullo C, Greco M, Cresta S, Piranda D, Holmes A, Fabbri G, Messina M, Rinaldi A, Wang J, Agostinelli C, Piccaluga PP, Lucioni M, Tabbò F, Serra R, Franceschetti S, Deambrogi C, Daniele G, Gattei V, Marasca R, Facchetti F, Arcaini L, Inghirami G, Bertoni F, Pileri SA, Deaglio S, Foà R, Dalla-Favera R, Pasqualucci L, Rabadan R, Gaidano G.
    The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development.
    J Exp Med, 209:1537-1551, 2012
  133. Rossi D.
    Richter syndrome and fludarabine: a controversial relationship.
    Leuk Lymphoma, 54:213-4, 2013
  134. Vaisitti T, Serra S, Pepper C, Rossi D, Laurenti L, Gaidano G, Malavasi F, Deaglio S.
    CD38 signals up-regulate expression and functions of matrix metalloproteinase-9 in chronic lymphocytic leukemia cells.
    Leukemia, 27:1177-81, 2013
  135. Zucchetto A, Vaisitti T, Benedetti D, Tissino E, Bertagnolo V, Rossi D, Bomben R, Dal Bo M, Del Principe MI, Gorgone A, Pozzato G, Gaidano G, Del Poeta G, Malavasi F, Deaglio S, Gattei V.
    The CD49d/CD29 complex is physically and functionally associated with CD38 in B-cell chronic lymphocytic leukemia cells.
    Leukemia, 26:1301-1312, 2012
  136. Rossi D, Gaidano G.
    Molecular genetics of high-risk chronic lymphocytic leukemia
    Expert Rev Hematol, 5:593-602, 2012
  137. Del Poeta G, Dal Bo M, Del Principe MI, Pozzo F, Rossi FM, Zucchetto A, Bomben R, Degan M, Rasi S, Rossi D, Bulian P, Gaidano G, Amadori S, Gattei V.
    Clinical significance of c.7544-7545delCT NOTCH1 mutation in chronic lymphocytic leukaemia.
    Br J Haematol, 160:415-8, 2013
  138. Rossi D, Rasi S, Spina V, Bruscaggin A, Monti S, Ciardullo C, Deambrogi C, Khiabanian H, Serra R, Bertoni F, Forconi F, Laurenti L, Marasca R, Dal-Bo M, Rossi FM, Bulian P, Nomdedeu J, Del Poeta G, Gattei V, Pasqualucci L, Rabadan R, Foà R, Dalla-Favera R, Gaidano G.
    Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia.
    Blood, 121:1403-12, 2013
  139. De Paoli L, Cerri M, Monti S, Rasi S, Spina V, Bruscaggin A, Greco M, Ciardullo C, Famà R, Cresta S, Maffei R, Ladetto M, Martini M, Laurenti L, Forconi F, Marasca R, Larocca LM, Bertoni F, Gaidano G, Rossi D.
    MGA, a suppressor of MYC, is recurrently inactivated in high risk chronic lymphocytic leukemia.
    Leuk Lymphoma, 54:1087-90, 2013
  140. Foà R, Del Giudice I, Guarini A, Rossi D, Gaidano G.
    Clinical implications of the molecular genetics of chronic lymphocytic leukemia.
    Haematologica, 98:675-85, 2013
  141. Rossi D.
    MYC addiction in chronic lymphocytic leukemia
    Leuk Lymphoma, 54:905-6, 2013
  142. Dal Bo M, Pozzo F, Bomben R, Degan M, Marconi D, Zucchetto A, Rossi D, Pozzato G, Zauli G, Gaidano G, Del Poeta G, Gattei V.
    ARHGDIA, a mutant TP53-associated Rho GDP dissociation inhibitor, is over-expressed in gene expression profiles of TP53 disrupted chronic lymphocytic leukaemia cells.
    Br J Haematol, 161:596-9, 2013
  143. Mian M, Rinaldi A, Mensah AA, Rossi D, Ladetto M, Forconi F, Marasca R, Uhr M, Stussi G, Kwee I, Cavalli F, Gaidano G, Zucca E, Bertoni F.
    Large genomic aberrations detected by SNP array are independent prognosticators of a shorter time to first treatment in chronic lymphocytic leukemia patients with normal FISH.
    Ann Oncol, 24:1378-84, 2013
  144. Sava GP, Speedy HE, Di Bernardo MC, Deaglio S, Karabon L, Frydecka I, Woszczyk D, Rossi D, Gaidano G, Mansouri L, Smedby KE, Juliusson G, Rosenquist R, Catovsky D, Houlston RS.
    rs2072135, A low-penetrance variant for chronic lymphocytic leukaemia?
    Br J Haematol, 162:221-8, 2013
  145. Rossi D, Ciardullo C, Gaidano G.
    Genetic aberrations of signaling pathways in lymphomagenesis: Revelations from next generation sequencing studies.   
    Semin Cancer Biol, 2013 doi:pii: S1044-579X(13)00042-4.            10.1016/j.semcancer.2013.04.002.
  146. Marasca R, Maffei R, Martinelli S, Fiorcari S, Bulgarelli J, Debbia G, Rossi D, Rossi FM, Rigolin GM, Martinelli S, Gattei V, Del Poeta G, Laurenti L, Forconi F, Montillo M, Gaidano G, Luppi M.
    Clinical heterogeneity of de novo 11q deletion chronic lymphocytic leukaemia: prognostic relevance of extent of 11q deleted nuclei inside leukemic clone.
    Hematol Oncol, 31:348-55, 2013 
  147. Brusa D, Serra S, Coscia M, Rossi D, D'Arena G, Laurenti L, Jaksic O, Fedele G, Inghirami G, Gaidano G, Malavasi F, Deaglio S.
    The PD-1/PD-L1 axis contributes to T-cell dysfunction in chronic lymphocytic leukemia.
    Haematologica, 98:953-63, 2013 
  148. Rossi D, Spina V, Bomben R, Rasi S, Dal-Bo M, Bruscaggin A, Rossi FM, Monti S, Degan M, Ciardullo C, Serra R, Zucchetto A, Nomdedeu J, Bulian P, Grossi A, Zaja F, Pozzato G, Laurenti L, Efremov DG, Di-Raimondo F, Marasca R, Forconi F, Del Poeta G, Gaidano G, Gattei V.
    Association between molecular lesions and specific B-cell receptor subsets in chronic lymphocytic leukemia.
    Blood, 121:4902-5, 2013 
  149. Rossi D
    Inherited suceptibility of chronic lymphocytic leukemia: The good candidates.
    Leuk Lymphoma, 2013 doi:10.3109/10428194.2013.810741 
  150. Bringhen S, Mateos MV, Zweegman S, Larocca A, Falcone AP, Oriol A, Rossi D, Cavalli M, Wijermans P, Ria R, Offidani M, Lahuerta JJ, Liberati AM, Mina R, Callea V, Schaafsma M, Cerrato C, Marasca R, Franceschini L, Evangelista A, Teruel AI, van der Holt B, Montefusco V, Ciccone G, Boccadoro M, Miguel JS, Sonneveld P, Palumbo A.
    Age and organ damage correlate with poor survival in myeloma patients: meta-analysis of 1435 individual patient data from 4 randomized trials.
    Haematologica, 98:980-7, 2013
  151. Varettoni M, Zibellini S, Capello D, Arcaini L, Rossi D, Pascutto C, Rattotti S, Mangiacavalli S, Pochintesta L, Gotti M, Gaidano G, Cazzola M.
    Clues to pathogenesis of Waldenström macroglobulinemia and immunoglobulin M monoclonal gammopathy of undetermined significance provided by analysis of immunoglobulin heavy chain gene rearrangement and clustering of B-cell receptors.
    Leuk Lymphoma, 2013 doi:10.3109/10428194.2013.779689
This is Schools Diazo Plone Theme